Canadian Biomaterials Society
La Société Canadienne des Biomatériaux

News All News

CBS Eastern Canada Research Day - Abstracts due Sept 15th 0 comments

by Patricia Comeau
Dear CBS Members Colleagues, We are excited to share that four of our Eastern Canada student chapters have organized a 2025 Canadian Biomaterials Society Eastern Canada Student Research Day ...
more

CBS Board of Directors Elections 2025 and CBS2027 Update 0 comments

by Lindsay Fitzpatrick
Dear CBS Member, I have a two important news items to communicate 1. CBS Board Member Elections It is now time to cast your votes for open positions on the CBS Board of Directors...
more

CBS Open Award Call: WBC 2016 Legacy Postdoctoral Experience Award 0 comments

by Patricia Comeau
Dear CBS Members, The Canadian Biomaterials Society CBS would like to encourage all postdoctoral fellows PDFs to consider applying for our WBC 2016 Legacy Postdoctoral Experience Award...
more

Meetings All Meetings

Discover

Pleiotrophin/heparin-Modified Type 1 Collagen Gels for Improved Re-Endothelialisation comments

by Francesco Copes
Arterial bypass graft is the primary therapy for patients with advanced vascular occlusion diseases and, in recent years, the development of tissue-engineered vascular grafts has emerged as a promising, clinically applicable alternative to autografts...
more

FXIIIa-Crosslinkable Synthetic Macromers Improve Stiffness and Adhesion of Hemophilia B Blood Clots under Fibrinolytic Conditions comments

by Christian Kastrup Karen Chan
Hemophilia is a bleeding disorder that affects roughly 1 in 5000 live births. A form of this disease, hemophilia B, is caused by deficiencies of the clotting protein, factor IX FIX , which is part of the coagulation cascade that, when activated by vascular injury, generates fibrin and its crosslinker, factor XIIIa FXIIIa ...
more

Immune Response to Allogeneic Islets in a Methacrylic Acid (MAA)-induced, Vascularized Subcutaneous Space comments

by Michael Sefton So-Yoon Won
Type I diabetes mellitus T1DM is an autoimmune disease that results in the destruction of pancreatic b-cells 1 ...
more

Genetically modified endothelial cells by non­viral (polymeric) vectors: An effective approach to enhance the osteogenic potential of bone marrow mesenchymal stem cells. comments

by Hasan Uludag
Genetically tailored human mesenchymal stem cells MSC are studied extensively to develop cell-based therapies for bone defects...
more

Connect

Active Job Postings

  • Postdoctoral Researcher in Conductive Polymer–Based Supercapacitors
    more
  • TIER 2 CANADA RESEARCH CHAIR IN CELL ENGINEERING AND BIOMANUFACTURING
    more
  • Assistant, Associate, or Full Professor in Bioprocessing and Biomanufacturing
    more
  • Research Associate in Next-Generation RNA Therapeutics at UBC
    more

Recent Member Projects

  • Dena Shahriari: AI-enhanced image processing
    more
  • Dena Shahriari: Biomaterials for spinal cord repair
    more
  • Dena Shahriari: Smart biomaterials for bladder management
    more
  • Dena Shahriari: Neuromodulation device development
    more

Recent Member Publications

  • Robyn Birch: Denosumab treatment of giant cell tumors in the spine induces woven bone formation
    more
  • Daniel Nguyen: Mechanically Stable and Tunable Photoactivated Peptide-Based Hydrogels for Soft Tissue Adhesion
    more
  • German Andres Mercado: Mechanically Stable and Tunable Photoactivated Peptide-Based Hydrogels for Soft Tissue Adhesion
    more
  • German Andres Mercado: Multipurpose On-the-Spot Peptide-Based Hydrogels for Skin, Cornea and Heart Repair
    more
Close Drag